Inorganic nanoporous membranes for immunoisolated cell-based drug delivery

Advances in Experimental Medicine and Biology

Volumn 670, Issue , 2010, Pages 104-125

  Mendelsohn, Adam ^b   Desai, Tejal ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLIC ACID; ALUMINUM OXIDE; COPOLYMER; GLUCOSE; IMMUNOSUPPRESSIVE AGENT; INORGANIC COMPOUND; INSULIN; POLYMER; POLYVINYLCHLORIDE; SILICON; TITANIUM DIOXIDE; NANOMATERIAL; TITANIUM;

ALLOTRANSPLANTATION; ARTICLE; ARTIFICIAL MEMBRANE; BIOCOMPATIBILITY; CELL ISOLATION; COMMERCIAL PHENOMENA; DRUG DELIVERY SYSTEM; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MICROCAPSULE; NANOBIOTECHNOLOGY; NANOENCAPSULATION; NANOPHARMACEUTICS; NONHUMAN; PANCREAS DISEASE; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; XENOTRANSPLANTATION; ANIMAL; CHEMISTRY; DRUG FORMULATION; IMMUNOLOGY; METABOLISM; POROSITY; REVIEW;

ALUMINUM OXIDE; ANIMALS; DIABETES MELLITUS, TYPE 1; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; MEMBRANES, ARTIFICIAL; NANOSTRUCTURES; POROSITY; SILICON; TITANIUM;

EID: 77951648990     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-5786-3_10     Document Type: Article

References (110)

1. Perlow MJ, Brain grafting as a treatment for parkinson's disease. Neurosurgery 1987; 20(2):335-42. (Pubitemid 17018963)
2. Roberts T, De Boni U, Sefton MV. Dopamine secretion by PC12 cells microencapsulated in a hydroxyethyl methacrylate-methyl methacrylate copolymer. Biomaterials 1996; 17(3):267-75. (Pubitemid 26031380)
3. Machluf M et al. Microencapsulation of leydig cells: A system for testosterone supplementation. Endocrinology 2003; 144(11):4975-9. (Pubitemid 37378412)
4. Dixit V, Gitnick G. Transplantation of microencapsulated hepatocytes for liver function replacement. J Biomater Sci Polym Ed 1995; 7(4):343-57.
5. Banting FG, Best CH, Collip JB et al. Pancreatic extracts in the treatment of diabetes mellitus: Preliminary report. CMAJ 1922; 12(3):141-146.
6. Minino AM et al. Deaths: Final data for 2004. Natl Vital Stat Rep 2007; 55(19):1-119.
7. Catargi B. Current status and future of implantable insulin pumps for the treatment of diabetes. Expert Rev Med Devices 2004; 1(2):181-5. (Pubitemid 40220430)
8. Gray DW. Encapsulated islet cells: The role of direct and indirect presentation and the relevance to xenotransplantation and autoimmune recurrence. Br Med Bull 1997; 53(4):777-88. (Pubitemid 27500804)
9. de Vos P et al. Association between macrophage activation and function of micro-encapsulated rat islets. Diabetologia 2003; 46(5):666-73. (Pubitemid 36808186)
10. Bertuzzi F et al. Tissue factor and CCL2/monocyte chemoattractant protein-1 released by human islets affect islet engraftment in type 1 diabetic recipients. J Clin Endocrinol Metab 2004; 89(11):5724-8.
11. Piro S et al. Bovine islets are less susceptible than human islets to damage by human cytokines. Transplantation 2001; 71(1):21-6. (Pubitemid 32105773)
12. Voltarelli JC et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. P 2007; 297(14):1568-76.
13. Gummert JF, Ikonen T, Morris RE. Newer immunosuppressive drugs: A review. J Am Soc Nephrol 1999; 10(6):1366-80. (Pubitemid 29247004)
14. Penn I. Post-transplant malignancy: The role of immunosuppression. Drug Saf 2000; 23(2):101-13.
15. Bretzel RG. Current status and perspectives in clinical islet transplantation. J Hepatobiliary Pancreat Surg 2000; 7(4):370-3.
16. Shapiro AM et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid- free immunosuppressive regimen. N Engl J Med 2000; 343(4):230-8. (Pubitemid 30490390)
17. Ryan EA et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54(7):2060-9. (Pubitemid 40911269)
18. Efrat S. Cell replacement therapy for type 1 diabetes. Trends Mol Med 2002; 8(7):334-39. (Pubitemid 34733387)
19. D'Amour KA et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 2006; 24(11):1392-401. (Pubitemid 44722103)
20. Gray DW. Comment on "reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection". Xenotransplantation 2004; 11(5):394-5. (Pubitemid 39128208)
21. Lacy PE, Davie JM, Finke EH. Prolongation of islet allograft survival following in vitro culture (24 degrees C) and a single injection of ALS. Science 1979; 204(4390):312-3. (Pubitemid 9159646)
22. Rogers SA et al. Islet cell engraftment and control of diabetes in rats after transplantation of pig pancreatic anlagen. Am J Physiol Endocrinol Metab 2004; 286(4):E502-9. (Pubitemid 38374946)
23. Hammerman MR. Transplantation of embryonic organs-kidney and pancreas. Am J Transplant 2004; 4(Suppl 6):14-24.
24. Eventov-Friedman S et al. Embryonic pig pancreatic tissue transplantation for the treatment of diabetes. PLoS Med 2006; 3(7):e215.
25. Mandel TE. Fetal islet xenotransplantation in rodents and primates. J Mol Med 1999; 77(1):155-60. (Pubitemid 29146208)
26. Bisceglie VV. Uber die antineoplastiche Immunitat. E Krebsforch 1933; 40(141).
27. Algire GH, Legallais FY. Recent developments in the transparent-chamber technique as adapted to the mouse. J Natl Cancer Inst 1949; 10(2):225-53, incl 8 pl.
28. Algire GH, Weaver JM, Prehn RT. Growth of cells in vivo in diffusion chambers. I. Survival of homografts in immunized mice. J Natl Cancer Inst 1954; 15(3):493-507.
29. Prehn RT, Weaver JM, Algire GH. The diffusion-chamber technique applied to a study of the nature of homograft resistance. J Natl Cancer Inst 1954; 15(3):509-17.
30. Weaver JM, Algire GH, Prehn RT. The growth of cells in vivo in diffusion chambers. II. The role of cells in the destruction of homografts in mice. J Natl Cancer Inst 1955; 15(6):1737-67.
31. Moskalewski S. Isolation and culture of the islets of langerhans of the guinea pig. Gen Comp Endocrinol 1965; 44:342-53.
32. Lanza RP, Hayes JL, Chick WL. Encapsulated cell technology. Nat Biotechnol 1996; 14(9):1107-11. (Pubitemid 26299109)
33. Maki T. Islet transplantation in the future: Use of a bioartificial pancreas. J Hep Bil Pancr Surg 1996; 3:275-279. (Pubitemid 126723114)
34. Scharp DW, Mason NS, Sparks RE. Islet immuno-isolation: The use of hybrid artificial organs to prevent islet tissue rejection. World J Surg 1984; 8(2):221-9. (Pubitemid 15019206)
35. Slater NJ, Raftery AT, Cope GH. The ultrastructure of human abdominal mesothelium. J Anat 1989; 167:47-56. (Pubitemid 20036020)
36. Chick WL, Like AA, Lauris V. Beta cell culture on synthetic capillaries: An artificial endocrine pancreas. Science 1975; 187(4179):847-9.
37. Knazek RA et al. Cell culture on artificial capillaries: An approach to tissue growth in vitro. Science 1972; 178(56):65-6.
38. Orsetti A et al. Implantation of a bio-artificial insulin distributor in dogs, using islets of Langerhans from different animal species. C R Seances Soc Biol Fil 1978; 172(1):144-50. (Pubitemid 8359108)
39. Sun AM et al. The use, in diabetic rats and monkeys, of artificial capillary units containing cultured islets of Langerhans (artificial endocrine pancreas). Diabetes 1977; 26(12):1136-9. (Pubitemid 8283434)
40. Tze WJ et al. Implantable artificial endocrine pancreas unit used to restore normoglycaemia in the diabetic rat. Nature 1976; 264(5585):466-7.
41. Sullivan SJ et al. Biohybrid artificial pancreas: Long-term implantation studies in diabetic, pancreatectomized dogs. Science 1991; 252(5006):718-21. (Pubitemid 21917002)
42. Theodorou NA, Howell SL. An assessment of diffusion chambers for use in pancreatic islet cell transplantation. Transplantation 1979; 27(5):350-2.
43. Colton CK. Implantable biohybrid artificial organs. Cell Transplant 1995; 4(4):415-36.
44. Yang H et al. Comparative studies of in vitro and in vivo function of three different shaped bioartificial pancreases made of agarose hydrogel. Biomaterials 1994; 15(2):113-20. (Pubitemid 24060609)
45. Chang TM. Semipermeable microcapsules. Science 1964; 146:524-5.
46. Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980; 210(4472):908-10. (Pubitemid 11169847)
47. O'Shea GM, Goosen MF, Sun AM. Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane. Biochim Biophys Acta 1984; 804(1):133-6.
48. Klock G et al. Production of purified alginates suitable for use in immunoisolated transplantation. Appl Microbiol Biotechnol 1994; 40(5):638-43. (Pubitemid 24048821)
49. Otterlei M et al. Induction of cytokine production from human monocytes stimulated with alginate. J Immunother 1991; 10(4):286-91.
50. Sefton MV, Stevenson WTK. Microencapsulation of live animal cells using polyacrylates. Adv Polym Sci 1993; 107:143-197.
51. Sawhney AS, Pathak CP, Hubbell JA. Interfacial photopolymerization of poly(ethylene glycol)-based hydrogels upon alginate-poly(l-lysine) microcapsules for enhanced biocompatibility. Biomaterials 1993; 14(13):1008-16. (Pubitemid 23323537)
52. Peterson KP, Peterson CM, Pope EJ. Silica sol-gel encapsulation of pancreatic islets. Proc Soc Exp Biol Med 1998; 218(4):365-9.
53. Wang T et al. An encapsulation system for the immunoisolation of pancreatic islets. Nat Biotechnol 1997; 15(4):358-62. (Pubitemid 27150252)
54. de Vos P et al. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials 2006; 27(32):5603-17.
55. Orive G et al. History, challenges and perspectives of cell microencapsulation. Trends Biotechnol 2004; 22(2):87-92. (Pubitemid 38130176)
56. Calafiore R et al. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: First two cases. Diabetes Care 2006; 29(1):137-8. (Pubitemid 44033446)
57. Novocell presents phase I/II data on safety and response to encapsulated islets at the American Diabetes Association's 66th annual scientific session, in http://novocell.com/news/press/2006-06-12.html. 2006, Accessed 5 December, 2007.
58. Soon-Shiong P et al. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 1994; 343(8903):950-1. (Pubitemid 24117231)
59. Living Cell Technologies updates shareholders on clinical trial progress at annual general meeting, in http://www.lctglobal.com/news/LCT%20AGM%20update. pdf. Accessed 5 December, 2007.
60. MicroIlset and Progenitor Cell Therapy enter into agreement for the manufacturing of MicroIslet-P, an encapsulated islet cell product for the treatment of type 1 diabetes, in http://phx.corporate-ir.net/phoenix. zhtml?c 122178&p irol-newsArticle&t Regular&id 1053966&. Accessed 5 December, 2007.
61. King A. Microencapsulation of islets of Langerhans: Impact of cellular overgrowth. Ups J Med Sci 2001; 106(3):161-74.
62. De Vos P et al. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes 1999; 48(7):1381-8. (Pubitemid 29297299)
63. Sabatine MS et al. Delayed rejection of soluble tumor necrosis factor receptor-secreting tumor allografts. Transplantation 1998; 65(1):113-20. (Pubitemid 28100442)
64. Sandberg JO et al. Treatment with an interleukin-1 receptor antagonist protein prolongs mouse islet allograft survival. Diabetes 1993; 42(12):1845-51.
65. Dunleavy M. Polymeric membranes. A review of applications. Med Device Technol 1996; 7(4):14-6, 18-21.
66. Weber CJ et al. Evaluation of graft-host response for various tissue sources and animal models. Ann N Y Acad Sci 1999; 875:233-54. (Pubitemid 29349075)
67. De Vos P et al. Factors influencing the adequacy of microencapsulation of rat pancreatic islets. Transplantation 1996; 62(7):888-93. (Pubitemid 26360346)
68. Teramura Y, Kaneda Y, Iwata H. Islet-encapsulation in ultra-thin layer-by-layer membranes of poly(vinyl alcohol) anchored to poly(ethylene glycol)-lipids in the cell membrane. Biomaterials 2007; 28:4818-4825. (Pubitemid 47285341)
69. Wang RN, Rosenberg L. Maintenance of beta-cell function and survival following islet isolation requires re-establishment of the islet-matrix relationship. J Endocrinol 1999; 163(2):181-90.
70. Gates RJ et al. Return to normal of blood-glucose, plasma-insulin and weight gain in New Zealand obese mice after implantation of islets of langerhans. Lancet 1972; 2(7777):567-70.
71. Strautz RL. Studies of hereditary-obese mice (obob) after implantation of pancreatic islets in Millipore filter capsules. Diabetologia 1970; 6(3):306-12.
72. Beck J et al. Islet encapsulation: Strategies to enhance islet cell functions. Tissue Eng 2007; 13(3):589-99. (Pubitemid 46579884)
73. Lysaght MJ et al. Recent progress in immunoisolated cell therapy. J Cell Biochem 1994; 56(2):196-203. (Pubitemid 24318397)
74. Loudovaris T et al. Correction of diabetic nod mice with insulinomas implanted within Baxter immunoisolation devices. J Mol Med 1999; 77(1):219-22. (Pubitemid 29146222)
75. Pioneer Surgical Technology acquires Encelle, Inc., in http://encelle.com. Accessed 5 December, 2007.
76. Smith C et al. Diffusion characteristics of microfabricated silicon nanopore membranes as immunoisolation membranes for use in cellular therapeutics. Diabetes Technol Ther 2005; 7(1):151-62. (Pubitemid 40354585)
77. Desai TA, et al. Microfabricated biocapsules provide short-term immunoisolation of insulinoma xenografts. Biomed Microdevices 1999; 1(2):131-8. (Pubitemid 129645134)
78. Desai TA et al. Microfabricated immunoisolating biocapsules. Biotechnol Bioeng 1998; 57(1):118-20. (Pubitemid 27514707)
79. Storrs R et al. Preclinical development of the islet sheet. Ann N Y Acad Sci 2001; 944:252-66. (Pubitemid 34053311)
80. Chu WH et al. Silicon membrane nanofilters from sacrificial oxide removal. JMEMS 1999; 8(1):34-42.
81. Leoni L, Desai TA. Micromachined biocapsules for cell-based sensing and delivery. Adv Drug Deliv Rev 2004; 56(2):211-29. (Pubitemid 38114932)
82. Leoni L, Attiah, Darlene et al. Nanoporous platforms for cellular sensing and delivery. Sensors 2002; 2:111-120. (Pubitemid 40643509)
83. Desai TA et al. Nanoporous anti-fouling silicon membranes for biosensor applications. Biosens Bioelectron 2000; 15(9-10):453-62.
84. Leoni L, Boiarski, Anthony et al. Characterization of nanoporous membranes for immunoisolation: Diffusion properties and tissue effects. Biomedical Microdevices 2002; 4(2):131-139. (Pubitemid 34449941)
85. Desai TA, Hansford DJ, Ferrari M. Characterization of micromachined silicon membranes for immunoisolation and bioseparation applications. J of Mem Sci 1999(159):221-231. (Pubitemid 29243858)
86. Desai TA et al. Nanoporous microsystems for islet cell replacement. Adv Drug Deliv Rev 2004; 56(11):1661-73. (Pubitemid 39177695)
87. Desai TA, Hansford DJ, Ferrari M. Micromachined interfaces: New approaches in cell immunoisolation and biomolecular separation. Biomol Eng 2000; 17(1):23-36.
88. La Flamme KE et al. Nanoporous alumina capsules for cellular macroencapsulation: Transport and biocompatibility. Diabetes Technol Ther 2005; 7(5):684-94. (Pubitemid 41572069)
89. Chou SY et al. Sub-10 nm imprint lithography and applications. J Vac Sci Technol B 1997; 15(6):2897-2904. (Pubitemid 127585648)
90. Masuda H, Fukuda K. Ordered metal nanohole arrays made by a two-step replication of honeycomb structures of anodic alumina. Science 1995; 268:1466-1468.
91. Masuda H, Satoh M. Fabrication of gold nanodot array using anodic porous alumina as an evaporation mask. Jpn J Appl Phys 1996; 35:126-129.
92. Gong D et al. Controlled molecular release using nanoporous alumina capsules. Biomedical Microdevices 2003; 5(1):75-80. (Pubitemid 38095900)
93. Popat KC et al. Surface modification of nanoporous alumina surfaces with poly(ethylene glycol). Langmuir 2004; 20(19):8035-41.
94. Itoh N et al. Strengthened porous alumina membrane tube prepared by means of internal anodic oxidation. Microporous and Mesoporous Materials 1998; 20:333-337. (Pubitemid 128353241)
95. Swan EE et al. Fabrication and evaluation of nanoporous alumina membranes for osteoblast culture. J Biomed Mater Res A 2005; 72(3):288-95. (Pubitemid 40270999)
96. Li AP et al. Polycrystalline nanopore arrays with hexagonal ordering on aluminum. J Vac Sci Technol A 1999; 17(4):1428-1431. (Pubitemid 129649432)
97. Thomas P et al. Immuno-allergological properties of aluminium oxide (Al2O3)ceramics and nickel sulfate in humans. Biomaterials 2003; 24(6):959-66. (Pubitemid 36020384)
98. La Flamme KE et al. Biocompatibility of nanoporous alumina membranes for immunoisolation. Biomaterials 2007; 28(16):2638-45. (Pubitemid 46367218)
99. Popat KC, Desai TA. Poly(ethylene glycol) interfaces: An approach for enhanced performance of microfluidic systems. Biosens Bioelectron 2004; 19(9):1037-44. (Pubitemid 38264488)
100. Beranek R, Hildebrand H, Schmuki P. Self-organized porous titanium oxide prepared in H2SO4/HF Electrolytes. Electrochemcial and Solid-State Letters 2003; 6(3):B12-B14.
101. Cai Q et al. The effect of electrolyte composition on the fabrication of self-organized titanium oxide nanotube arrays by anodic oxidation. J Mater Res 2004; 20(1):230-236. (Pubitemid 40970226)
102. Gong D, Grimes CA, Varghese OK. Titanium oxide nanotube arrays prepared by anodic oxidation. J Mater Res 2001; 16(12):3331-3334. (Pubitemid 34574314)
103. 2 nanotube arrays to 134 um in length. J of Phys Chem B 2006; 110(33):16179-16184. (Pubitemid 44373336)
104. 2 nanotube arrays using an organic electrolyte. J Phys Chem B 2005; 109:15754-15759. (Pubitemid 41321490)
105. Zhao J et al. In situ templated synthesis of anatase single-crystal nanotube arrays. Nanotechnology 2005; 16:2450-2454. (Pubitemid 41376193)
106. 2 Nanotube arrays of 1000 micron length by anodization of titanium foil: Phenol red diffusion. J Phys Chem C 2007; 111(41):14992-14997. (Pubitemid 350068881)
107. Mor GK, Varghese, Oomman K et al. Fabrication of tapered, conical-shaped titania nanotubes. J Mater Res 2003; 18(11).
108. 2 nanotubes by anodization of titanium. Angew. Chem Int Ed 2005; 44:2100-2102.
109. Choi J et al. Porous niobium oxide films prepared by anodization- annealing-anodization. Nanotechnology 2007; 18.
110. 4/HF Electrolytes. Electrochemical and Solid-State Letters 2005; 8(3):J10-J12. (Pubitemid 40407217)